Quantcast

Latest Aspirin Stories

1fd1b446a2a9d1a9d4009e1496f94409
2011-08-11 06:18:07

A systematic review published in The Cochrane Library did not find compelling evidence to support the routine use of aspirin in women being treated for IVF. The researchers reported that taking aspirin during an IVF cycle did not seem to increase a woman's chances of becoming pregnant. The use of aspirin during IVF treatment is controversial. Part of the thinking behind any potential benefit is that aspirin may improve the blood flow to the womb and ovaries. However, there are also concerns...

2011-07-28 14:42:00

BALTIMORE, July 28, 2011 /PRNewswire/ -- Baby boomers likely remember the iconic orange-flavored St. Joseph Aspirin used in their childhood. Today, St. Joseph Aspirin has tapped Ken Osmond to help promote the brand as something that can be "Good for You Again" as part of a doctor-recommended, low dose aspirin regimen to help prevent strokes and heart attacks. Best known as Eddie Haskell from "Leave it to Beaver," Ken will serve as a spokesperson in a multimedia campaign featuring a...

2011-07-26 07:00:00

MORRISTOWN, N.J., July 26, 2011 /PRNewswire/ -- Bayer HealthCare, the makers of new Bayer(®) Advanced Aspirin, is demonstrating its commitment to fast relief with the launch of Speed Up Your Relief, a new campaign that drives donations to the American Red Cross. Proven to relieve pain twice as fast* as previous Bayer Aspirin tablets, Bayer Advanced Aspirin is leveraging its new role as the "Official Pain Reliever of Major League Baseball" to turn fast strikes into...

2011-07-20 21:16:00

WILMINGTON, Del., July 20, 2011 /PRNewswire/ -- AstraZeneca (NYSE: AZN) announced today that the US Food and Drug Administration (FDA) has approved BRILINTA(TM) (ticagrelor) tablets to reduce the rate of heart attack (myocardial infarction [MI]) and cardiovascular (CV) death in adult patients with acute coronary syndrome (ACS), compared to clopidogrel. To view the multimedia assets associated with this release, please click: http://multivu.prnewswire.com/mnr/astrazeneca/50355/ BRILINTA,...

2011-07-20 16:04:00

Boxed warning says daily aspirin doses above 100 milligrams decrease effectiveness SILVER SPRING, Md., July 20, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved the blood-thinning drug Brilinta (ticagrelor) to reduce cardiovascular death and heart attack in patients with acute coronary syndromes (ACS). (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) ACS includes a group of symptoms for any condition, such as unstable angina or heart...

6ca341608fcab2d261d33c37e19d5892
2011-07-20 13:40:00

A new study has found that if heart disease patients stop taking aspirin it could raise their heart attack risk, reports BBC News. Researchers said that users stop taking aspirin against medical advice, which puts them at a 60 percent greater risk of a non-fatal heart attack. The findings come from a U.K. database of about 40,000 patients who had been prescribed the drug by their doctor. For the 1,000 patients that took part in the study, there were about four extra cases of non-fatal...

2011-07-13 13:32:46

According to new study in the American Journal of Medicine A study published in the July issue of The American Journal of Medicine, reports that among hypertensive patients with coronary artery disease, chronic self-reported use of non-steroidal anti-inflammatory drugs (NSAIDs) was associated with an increased risk of adverse events during long-term follow-up. Long-term NSAIDs use is common for treatment of chronic pain. Researchers from the Division of Cardiovascular Medicine, College of...

2011-06-27 12:00:00

DALLAS, June 27, 2011 /PRNewswire-USNewswire/ -- The following release is being issued by the American Heart Association: (Logo: http://photos.prnewswire.com/prnh/20100222/AHSALOGO) First patients receive lab-grown blood vessels from donor cells Study Highlights: For the first time, blood vessels created in the lab from donor skin cells were successfully implanted in patients. Functioning blood vessels that aren't rejected by the immune system could be used to make durable shunts for...

2011-05-23 13:56:00

MORRISTOWN, N.J., May 23, 2011 /PRNewswire/ -- Bayer HealthCare's Consumer Care division announced today the introduction of Bayer® Advanced Aspirin, the next generation of aspirin for pain relief. Using the patent-pending Pro-Release(TM) Technology, Bayer Advanced Aspirin is clinically proven to relieve tough pain twice as fast as previous Bayer® Aspirin tablets*. To view the multimedia assets associated with this release, go to:...

2011-05-19 06:53:48

(Ivanhoe Newswire) -- Regardless of the beneficial effects of both aspirin and simvastatin in treating heart disease, neither drug appears to offer any benefit to individuals suffering from pulmonary artery hypertension (PAH), a condition that accounts for over 1,000 new cases annually. Pulmonary arterial hypertension is a progressive disorder characterized by abnormally high blood pressure (hypertension) in the pulmonary artery, the blood vessel that carries blood from the heart to the...


Word of the Day
lambent
  • Licking.
  • Hence Running along or over a surface, as if in the act of licking; flowing over or along; lapping or bathing; softly bright; gleaming.
This word comes the Latin 'lambere,' to lick.
Related